Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000031

Chief Operating Officer sold 600 shares at $41.30 ($24,780)

From the SEC's structured data for this filing

Trades in this filing

Sandler Laura Lee · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-16 Sale : show line 1 in the form −600 $41.30 $24,780 236,984 D
Open-market sales · 600 sh · avg $41.30 · $24,780
Loading xslF345X05/form4.xml…